Imagine you have just completed an exhaustive DCF model on a mid-cap manufacturing firm. You are ready to issue a ‘Buy’ recommendation, feeling confident that your projections of free cash flow growth are robust. Before you hit the ‘publish’ button on your firm’s research portal, you must pause and verify that your document mirrors the rigid structure mandated by SEBI Regulation 20.
A research report is not merely a collection of your opinions; it is a legal document that must serve as a stand-alone proof of your due diligence and objectivity.
Regulation 20 serves as the blueprint for transparency. It dictates that every research report must clearly contain the name of the research analyst or the research entity, alongside a disclosure of their financial interest in the subject company. If your firm has received any compensation from the company in the past twelve months, or if you have served as an officer or director, this information cannot be buried in the fine print.
The regulation ensures that an investor understands exactly who is speaking and whether the messenger has a material stake in the outcome of the share price.
Consider the requirement regarding price targets. If you assign a target, you must also provide the duration of the target and the historical track record of your recommendations for that specific stock. This prevents the ‘hit-and-run’ style of analysis where an analyst issues a bullish target to grab headlines but fails to follow through when the fundamental thesis weakens. By requiring this longitudinal data, SEBI forces you to be accountable for your past errors and successes, directly linking your professional reputation to your output.
Practically, this means your research report must include a clear summary of your valuation methodology, whether it is a relative valuation approach using P/E multiples or an absolute approach like DCF. You must explicitly state the risks associated with the investment, such as regulatory hurdles or currency fluctuations, and describe the basis for your rating system.
For instance, if you categorize a stock as ‘Accumulate,’ your report must define what that means in terms of the expected upside relative to the broader market index, such as the Nifty 50. This standardized framework protects the investor from subjective interpretations and keeps your analysis grounded in verifiable, structured logic.
Nuance
Check Your Understanding
A research analyst is preparing a report on a pharmaceutical company. Under SEBI Regulation 20, which of the following is mandatory to include regarding the company’s valuation?
If a research analyst assigns a price target in their report, what must be disclosed regarding that target?
This is a companion read for Section 14.4 — Management of Conflicts of Interest and Disclosure Requirements for Research Analysts from PASS Research Analyst Certification Examination by Akhilesh Gururani, available on Amazon Kindle.
Copyright © 2026 Akhilesh Gururani. All rights reserved.